ATE514793T1 - Zusammensetzungen und verfahren für il13- biomarker - Google Patents

Zusammensetzungen und verfahren für il13- biomarker

Info

Publication number
ATE514793T1
ATE514793T1 AT06815683T AT06815683T ATE514793T1 AT E514793 T1 ATE514793 T1 AT E514793T1 AT 06815683 T AT06815683 T AT 06815683T AT 06815683 T AT06815683 T AT 06815683T AT E514793 T1 ATE514793 T1 AT E514793T1
Authority
AT
Austria
Prior art keywords
compositions
methods
biomarkers
measuring
determining biomarkers
Prior art date
Application number
AT06815683T
Other languages
English (en)
Inventor
Farhat Syed
Chong Huang
Katherine Li
Guihua Liu
Li Li
Xiaozhou Shang
Original Assignee
Centocor Ortho Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Ortho Biotech Inc filed Critical Centocor Ortho Biotech Inc
Application granted granted Critical
Publication of ATE514793T1 publication Critical patent/ATE514793T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • G01N2800/122Chronic or obstructive airway disorders, e.g. asthma COPD
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
AT06815683T 2005-09-30 2006-09-29 Zusammensetzungen und verfahren für il13- biomarker ATE514793T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72229605P 2005-09-30 2005-09-30
PCT/US2006/037856 WO2007041219A2 (en) 2005-09-30 2006-09-29 Compositions and methods for il13 biomarkers

Publications (1)

Publication Number Publication Date
ATE514793T1 true ATE514793T1 (de) 2011-07-15

Family

ID=37906704

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06815683T ATE514793T1 (de) 2005-09-30 2006-09-29 Zusammensetzungen und verfahren für il13- biomarker

Country Status (4)

Country Link
US (1) US7875427B2 (de)
EP (1) EP1943359B1 (de)
AT (1) ATE514793T1 (de)
WO (1) WO2007041219A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY144906A (en) 2005-10-21 2011-11-30 Novartis Ag Human antibodies against il13 and therapeutic uses
CN104812913B (zh) 2012-11-07 2019-03-15 私募蛋白质体公司 慢性阻塞性肺疾病(copd)生物标记及其用途
BR112016008694A2 (pt) * 2013-10-23 2017-10-03 Genentech Inc Métodos de previsão da reação de pacientes com asma, de previsão da capacidade de reação de pacientes com asma, de identificação de pacientes com asma, de tratamento de pacientes portadores de asma e de tratamento de asma, uso de um kit e kit
EA037960B1 (ru) 2016-04-27 2021-06-15 Эббви Инк. Способ лечения эозинофильного эзофагита с применением антитела против il-13

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194163B1 (en) * 1995-07-21 2001-02-27 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Method for the quantitative measurement of human acute phase serum amyloid A protein; recombinant protein; specific antibody
US5853697A (en) * 1995-10-25 1998-12-29 The United States Of America, As Represented By The Department Of Health & Human Services Methods of treating established colitis using antibodies against IL-12
JP4155561B2 (ja) 2000-12-26 2008-09-24 国立大学法人佐賀大学 アレルギー性疾患検査方法
JP2004121218A (ja) 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
MXPA05007466A (es) * 2003-01-09 2006-03-08 Arizeke Pharmaceuticals Inc Metodos para el tratamiento de enfermedades pulmonares.
WO2006124451A2 (en) 2005-05-11 2006-11-23 Centocor, Inc. Anti-il-13 antibodies, compositions, methods and uses

Also Published As

Publication number Publication date
WO2007041219A3 (en) 2007-10-04
US20070077585A1 (en) 2007-04-05
WO2007041219A2 (en) 2007-04-12
US7875427B2 (en) 2011-01-25
HK1123073A1 (en) 2009-06-05
EP1943359B1 (de) 2011-06-29
EP1943359A4 (de) 2009-10-14
EP1943359A2 (de) 2008-07-16

Similar Documents

Publication Publication Date Title
EP1869462A4 (de) Biomarker für ovarialkrebs und endometriumkrebs: hepcidin
DE602006001278D1 (de) Messinstrument für Oberflächenprofile
ATE424904T1 (de) Bausatz für komplexe konstruktionen
DE602006015521D1 (de) Messstreifen und verfahren für lateralfluss-testvorrichtungen
DE602006003488D1 (de) Einführeinrichtung für ein Instrument
EP1901654A4 (de) Messinstrument für perkutane operationen
DE602006017421D1 (de) Screening-verfahren für kokumi-vermittelnde agentien
DE602005009994D1 (de) Kalibration für Mixed Reality
EP1838732A4 (de) Biomarker für melanome
ATE449193T1 (de) Verfahren zur bestimmung der kopienummer
DE602006009202D1 (de) Formmessgerät
AR059096A1 (es) Anticuerpos anti- efrina -b2 y metodos que usan estos
DE602005005924D1 (de) Einheitliches Datenformat für Messgeräte
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
DE602004000991D1 (de) Gleitstruktur für Klavierinstrument
EP2300624A4 (de) Biomarker für schmerzhafte bandscheiben und verwendungsverfahren dafür
DE602006005208D1 (de) Tonerzusammensetzung und Verfahren
DE602005003146D1 (de) Polymer- Zusamensetzungen für verbesserte Materialien
DE602006015887D1 (de) Wiederaufnamesystem für Luftschiffe
ATE514793T1 (de) Zusammensetzungen und verfahren für il13- biomarker
DE602006009513D1 (de) Verwendung von phenylsemicarbazonen für die saatgutbeizung
DE602006015735D1 (de) Bodenbeschichtungszusammensetzung und Verwendung eines Zusatzes für Bodenbeschichtungszusammensetzung
DE602005003637D1 (de) Dichtung für Dämpfer
DE502005010620D1 (de) Obergurtquerschnitt für Kranteleskopteile
EP2403843A4 (de) Chemilumineszente zusammensetzungen, verfahren, tests und kits für oxidative enzyme

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties